Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis
- PMID: 30941323
- PMCID: PMC6444047
- DOI: 10.4174/astr.2019.96.4.191
Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis
Abstract
Purpose: Recently, the neutrophil-to-lymphocyte ratio (NLR), an inflammatory response marker, has been reported to be associated with the prognosis in patients with various type of cancer. However, there have been no studies until now that have explored the prognostic role of combined detection of NLR and CEA in patients with synchronous liver-limited colorectal metastases (sCRLM).
Methods: Eighty-three patients who histologically diagnosed as sCRLM were selected. Their laboratory and clinical data were collected retrospectively. Using receiver operating characteristic curve analysis, the cutoff value of NLR was calculated based on which patients were assigned to a high NLR (more than 1.94) group and low NLR (less than 1.94) group. A cutoff value of 100 ng/mL for serum CEA level was used in light of the previous literature.
Results: CEA level and Poorly differentiated histology of colon cancer was significantly correlated with high NLR (P = 0.005 and P = 0.048, respectively). The multivariate analysis identified the high NLR as independent prognostic factors for OS and DFS in all patients (P = 0.010 and P = 0.006, respectively). Patients with both low levels of NLR and CEA had a significantly longer OS and DFS (P = 0.026 and P = 0.009, respectively).
Conclusion: In conclusion, elevated preoperative NLR is strongly correlated with both survival and recurrence in patients who have been diagnosed with resectable sCRLM. The combination of NLR and CEA level could be a more powerful prognostic marker than NLR alone.
Keywords: Carinoembryonic antigen; Colonic neoplasms; Liver; Metastasis; Neutrophils; Prognosis.
Conflict of interest statement
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
Figures

Similar articles
-
Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone.Biomed Res Int. 2017;2017:3809464. doi: 10.1155/2017/3809464. Epub 2017 Jun 8. Biomed Res Int. 2017. PMID: 28685148 Free PMC article. Clinical Trial.
-
Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.Can J Gastroenterol Hepatol. 2022 Jan 4;2022:3109165. doi: 10.1155/2022/3109165. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 35028301 Free PMC article.
-
Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.Medicine (Baltimore). 2020 Mar;99(10):e19405. doi: 10.1097/MD.0000000000019405. Medicine (Baltimore). 2020. PMID: 32150090 Free PMC article.
-
The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.J Cell Physiol. 2018 May;233(5):4216-4224. doi: 10.1002/jcp.26239. Epub 2017 Dec 26. J Cell Physiol. 2018. PMID: 29057536
-
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.World J Surg Oncol. 2016 Nov 16;14(1):289. doi: 10.1186/s12957-016-1044-9. World J Surg Oncol. 2016. PMID: 27852294 Free PMC article.
Cited by
-
Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer With Liver Metastasis.Front Oncol. 2020 Oct 2;10:1681. doi: 10.3389/fonc.2020.01681. eCollection 2020. Front Oncol. 2020. PMID: 33123459 Free PMC article.
-
The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis.Cancer Cell Int. 2023 Feb 28;23(1):39. doi: 10.1186/s12935-023-02876-z. Cancer Cell Int. 2023. PMID: 36855112 Free PMC article. Review.
-
Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer.Ann Coloproctol. 2022 Apr;38(2):97-108. doi: 10.3393/ac.2021.01004.0143. Epub 2022 Mar 29. Ann Coloproctol. 2022. PMID: 35345306 Free PMC article. Review.
-
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.Cells. 2024 Oct 9;13(19):1666. doi: 10.3390/cells13191666. Cells. 2024. PMID: 39404428 Free PMC article. Review.
-
Prognostic role of serum carcinoembryonic antigen in patients receiving liver resection for colorectal cancer liver metastasis: A meta-analysis.World J Gastrointest Surg. 2023 Dec 27;15(12):2890-2906. doi: 10.4240/wjgs.v15.i12.2890. World J Gastrointest Surg. 2023. PMID: 38222018 Free PMC article.
References
-
- Bertens KA, Hawel J, Lung K, Buac S, Pineda-Solis K, Hernandez-Alejandro R. ALPPS: challenging the concept of unresectability--a systematic review. Int J Surg. 2015;13:280–287. - PubMed
-
- Sandstrom P, Rosok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, et al. ALPPS improves resectability ompared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial) Ann Surg. 2018;267:833–840. - PMC - PubMed
-
- Ozyalvacli G, Yesil C, Kargi E, Kizildag B, Kilitci A, Yilmaz F. Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer. Asian Pac J Cancer Prev. 2014;15:10363–10366. - PubMed
LinkOut - more resources
Full Text Sources